This is an N-ras oncogene encoding a membrane protein that shuttles between the Golgi apparatus and the plasma membrane. This shuttling is regulated through palmitoylation and depalmitoylation by the ZDHHC9-GOLGA7 complex. The encoded protein, which has intrinsic GTPase activity, is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase activating protein. Mutations in this gene have been associated with somatic rectal cancer, follicular thyroid cancer, autoimmune lymphoproliferative syndrome, Noonan syndrome, and juvenile myelomonocytic leukemia. [provided by RefSeq, Jun 2011]
这是一个N-ras致癌基因编码的高尔基体和质膜之间穿梭的膜蛋白。此穿梭通过棕榈酰化和depalmitoylation由ZDHHC9-GOLGA7复杂的调节。所编码的蛋白质,其具有内在的GTP酶活性,是由一个鸟嘌呤核苷酸交换因子激活和灭活由GTP酶激活蛋白。在这种基因突变与躯体直肠癌,甲状腺滤泡状癌,自身免疫性淋巴增生综合征,努南综合征,和幼年粒 - 单核细胞白血病相关。 [由RefSeq的,2011年6月提供]
NRAS基因(以及对应的蛋白质)的细胞分布位置:
NRAS基因的本体(GO)信息:
名称 |
---|
4014 Ras signaling pathway [PATH:hsa04014] |
4015 Rap1 signaling pathway [PATH:hsa04015] |
4010 MAPK signaling pathway [PATH:hsa04010] |
4012 ErbB signaling pathway [PATH:hsa04012] |
4370 VEGF signaling pathway [PATH:hsa04370] |
4068 FoxO signaling pathway [PATH:hsa04068] |
4071 Sphingolipid signaling pathway [PATH:hsa04071] |
4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
4810 Regulation of actin cytoskeleton [PATH:hsa04810] |
4530 Tight junction [PATH:hsa04530] |
4540 Gap junction [PATH:hsa04540] |
4550 Signaling pathways regulating pluripotency of stem cells [PATH:hsa04550] |
4650 Natural killer cell mediated cytotoxicity [PATH:hsa04650] |
4660 T cell receptor signaling pathway [PATH:hsa04660] |
4662 B cell receptor signaling pathway [PATH:hsa04662] |
4664 Fc epsilon RI signaling pathway [PATH:hsa04664] |
4062 Chemokine signaling pathway [PATH:hsa04062] |
4910 Insulin signaling pathway [PATH:hsa04910] |
4912 GnRH signaling pathway [PATH:hsa04912] |
4915 Estrogen signaling pathway [PATH:hsa04915] |
4917 Prolactin signaling pathway [PATH:hsa04917] |
4921 Oxytocin signaling pathway [PATH:hsa04921] |
4919 Thyroid hormone signaling pathway [PATH:hsa04919] |
4916 Melanogenesis [PATH:hsa04916] |
4725 Cholinergic synapse [PATH:hsa04725] |
4726 Serotonergic synapse [PATH:hsa04726] |
4720 Long-term potentiation [PATH:hsa04720] |
4730 Long-term depression [PATH:hsa04730] |
4722 Neurotrophin signaling pathway [PATH:hsa04722] |
4360 Axon guidance [PATH:hsa04360] |
5200 Pathways in cancer [PATH:hsa05200] |
5230 Central carbon metabolism in cancer [PATH:hsa05230] |
5231 Choline metabolism in cancer [PATH:hsa05231] |
5206 MicroRNAs in cancer [PATH:hsa05206] |
5205 Proteoglycans in cancer [PATH:hsa05205] |
5203 Viral carcinogenesis [PATH:hsa05203] |
5214 Glioma [PATH:hsa05214] |
5216 Thyroid cancer [PATH:hsa05216] |
5221 Acute myeloid leukemia [PATH:hsa05221] |
5220 Chronic myeloid leukemia [PATH:hsa05220] |
5218 Melanoma [PATH:hsa05218] |
5211 Renal cell carcinoma [PATH:hsa05211] |
5219 Bladder cancer [PATH:hsa05219] |
5215 Prostate cancer [PATH:hsa05215] |
5213 Endometrial cancer [PATH:hsa05213] |
5223 Non-small cell lung cancer [PATH:hsa05223] |
5034 Alcoholism [PATH:hsa05034] |
5166 HTLV-I infection [PATH:hsa05166] |
5161 Hepatitis B [PATH:hsa05161] |
5160 Hepatitis C [PATH:hsa05160] |
名称 |
---|
Activation of RAS in B cells |
Adaptive Immune System |
ARMS-mediated activation |
Axon guidance |
C-type lectin receptors (CLRs) |
CD209 (DC-SIGN) signaling |
Cell surface interactions at the vascular wall |
Constitutive Signaling by EGFRvIII |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants |
Cytokine Signaling in Immune system |
DAP12 interactions |
DAP12 signaling |
Developmental Biology |
Disease |
Diseases of signal transduction |
Downstream signal transduction |
Downstream signaling events of B Cell Receptor (BCR) |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
EGFR Transactivation by Gastrin |
Fc epsilon receptor (FCERI) signaling |
FCERI mediated MAPK activation |
FRS-mediated FGFR1 signaling |
FRS-mediated FGFR2 signaling |
FRS-mediated FGFR3 signaling |
Frs2-mediated activation |
FRS2-mediated FGFR4 signaling |
Gastrin-CREB signalling pathway via PKC and MAPK |
GRB2 events in EGFR signaling |
GRB2 events in ERBB2 signaling |
Hemostasis |
IGF1R signaling cascade |
Immune System |
Innate Immune System |
Insulin receptor signalling cascade |
Interleukin-2 signaling |
IRS-mediated signalling |
IRS-related events |
IRS-related events triggered by IGF1R |
MEK activation |
NCAM signaling for neurite out-growth |
NGF signalling via TRKA from the plasma membrane |
p38MAPK events |
Prolonged ERK activation events |
RAF activation |
RAF phosphorylates MEK |
RAF/MAP kinase cascade |
SHC-mediated cascade:FGFR1 |
SHC-mediated cascade:FGFR2 |
SHC-mediated cascade:FGFR3 |
SHC-mediated cascade:FGFR4 |
SHC-mediated signalling |
SHC-related events |
SHC-related events triggered by IGF1R |
SHC1 events in EGFR signaling |
SHC1 events in ERBB2 signaling |
SHC1 events in ERBB4 signaling |
Signaling by EGFR |
Signaling by EGFR in Cancer |
Signaling by EGFRvIII in Cancer |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR in disease |
Signaling by FGFR1 |
Signaling by FGFR1 in disease |
Signaling by FGFR1 mutants |
Signaling by FGFR2 |
Signaling by FGFR2 in disease |
Signaling by FGFR2 mutants |
Signaling by FGFR3 |
Signaling by FGFR3 in disease |
Signaling by FGFR3 mutants |
Signaling by FGFR4 |
Signaling by FGFR4 in disease |
Signaling by FGFR4 mutants |
Signaling by GPCR |
Signaling by Insulin receptor |
Signaling by Interleukins |
Signaling by Leptin |
Signaling by Ligand-Responsive EGFR Variants in Cancer |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by the B Cell Receptor (BCR) |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
Signaling by VEGF |
Signalling by NGF |
Signalling to ERKs |
Signalling to p38 via RIT and RIN |
Signalling to RAS |
SOS-mediated signalling |
Tie2 Signaling |
VEGFA-VEGFR2 Pathway |
VEGFR2 mediated cell proliferation |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Juvenile Myelomonocytic Leukemia | 0.489977336 | 19 | 3 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_ORPHANET_UNIPROT |
GIANT PIGMENTED HAIRY NEVUS | 0.360271442 | 3 | 3 | BeFree_CLINVAR_ORPHANET_UNIPROT |
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 0.36 | 1 | 1 | CLINVAR_ORPHANET_UNIPROT |
Noonan Syndrome 6 | 0.36 | 1 | 5 | CLINVAR_CTD_human_UNIPROT |
Noonan Syndrome | 0.241900093 | 7 | 0 | BeFree_CTD_human_ORPHANET |
NEVUS, EPIDERMAL (disorder) | 0.24 | 3 | 3 | CLINVAR_UNIPROT |
Neurocutaneous melanosis | 0.24 | 2 | 2 | CLINVAR_UNIPROT |
melanoma | 0.235804412 | 215 | 7 | BeFree_CTD_human_GAD_LHGDN |
Papillary thyroid carcinoma | 0.122638474 | 2 | 1 | BeFree_GAD_ORPHANET |
Colorectal Neoplasms | 0.122367032 | 1 | 0 | CTD_human_GAD |
关注微信订阅号,实时查看信息,关注医学生物学动态。